MeSH term
Frequency | Condition_Probility | Animals | 40 | 0.0 |
Cation Transport Proteins/*metabolism | 3 | 37.0 |
Copper/*metabolism | 25 | 27.0 |
Humans | 116 | 0.0 |
Research Support, Non-U.S. Gov't | 78 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 23 | 0.0 |
Adenosinetriphosphatase/*genetics | 30 | 30.0 |
Cation Transport Proteins/*genetics | 11 | 32.0 |
Copper/metabolism | 17 | 26.0 |
Gene Therapy | 2 | 0.0 |
Liver/pathology | 2 | 1.0 |
Microscopy, Fluorescence | 4 | 0.0 |
Rats | 13 | 0.0 |
Rats, Inbred LEC | 4 | 57.0 |
Reverse Transcriptase Polymerase Chain Reaction | 8 | 0.0 |
Adult | 20 | 0.0 |
Base Sequence | 21 | 0.0 |
DNA Mutational Analysis | 16 | 0.0 |
Female | 38 | 0.0 |
Gene Frequency | 6 | 0.0 |
Haplotypes | 5 | 0.0 |
Hepatolenticular Degeneration/*genetics | 19 | 70.0 |
Male | 26 | 0.0 |
*Mutation | 14 | 0.0 |
Adenosinetriphosphatase/*genetics/metabolism | 7 | 26.0 |
Aged | 4 | 0.0 |
Aged, 80 and over | 2 | 0.0 |
*Arabidopsis Proteins | 2 | 2.0 |
Cation Transport Proteins/*genetics/metabolism | 3 | 60.0 |
Immunoenzyme Techniques | 2 | 0.0 |
Middle Aged | 4 | 0.0 |
*Neoplasm Proteins | 2 | 0.0 |
RNA, Messenger/metabolism | 2 | 0.0 |
Tumor Cells, Cultured | 11 | 0.0 |
Adolescent | 15 | 0.0 |
Ceruloplasmin/analysis | 3 | 10.0 |
Child | 14 | 0.0 |
China | 2 | 0.0 |
Mutation | 18 | 0.0 |
Adenosinetriphosphatase/*chemistry/genetics/metabolism | 2 | 66.0 |
Cation Transport Proteins/*chemistry/genetics/metabolism | 2 | 100.0 |
Proteasome Endopeptidase Complex | 2 | 0.0 |
Protein Conformation | 3 | 0.0 |
Adenosinetriphosphatase/*biosynthesis | 2 | 50.0 |
Antineoplastic Agents/*pharmacology | 3 | 0.0 |
Cation Transport Proteins/*biosynthesis | 2 | 66.0 |
Cisplatin/*pharmacology | 4 | 3.0 |
Drug Resistance, Neoplasm | 6 | 1.0 |
Drug Screening Assays, Antitumor | 2 | 0.0 |
RNA, Messenger/analysis | 2 | 0.0 |
English Abstract | 9 | 0.0 |
Exons/genetics | 2 | 0.0 |
Gene Deletion | 2 | 0.0 |
Hepatolenticular Degeneration/epidemiology/*genetics | 2 | 100.0 |
Point Mutation/*genetics | 2 | 0.0 |
Polymerase Chain Reaction | 13 | 0.0 |
Carrier Proteins/*genetics | 18 | 1.0 |
*Cation Transport Proteins | 49 | 22.0 |
Exons | 10 | 0.0 |
Polymorphism, Single-Stranded Conformational | 11 | 0.0 |
Chelating Agents/therapeutic use | 2 | 28.0 |
Copper | 3 | 15.0 |
Homozygote | 4 | 0.0 |
Sequence Analysis, DNA | 3 | 0.0 |
CHO Cells | 5 | 0.0 |
Fluorescent Antibody Technique | 7 | 0.0 |
Hamsters | 8 | 0.0 |
Hepatolenticular Degeneration/*genetics/metabolism | 4 | 100.0 |
Sheep | 3 | 0.0 |
Transfection | 7 | 0.0 |
Adenosinetriphosphatase/*chemistry/genetics/*metabolism | 3 | 60.0 |
Carrier Proteins/*chemistry/genetics/*metabolism | 2 | 4.0 |
Copper/metabolism/*pharmacology | 4 | 50.0 |
Kinetics | 5 | 0.0 |
Menkes Kinky Hair Syndrome/*genetics | 4 | 18.0 |
Models, Molecular | 5 | 0.0 |
Phosphorylation | 3 | 0.0 |
Plasmids | 2 | 0.0 |
Protein Structure, Secondary | 4 | 0.0 |
*Recombinant Fusion Proteins | 11 | 18.0 |
Genotype | 13 | 0.0 |
Phenotype | 10 | 0.0 |
Adenosinetriphosphatase/*analysis | 2 | 100.0 |
*Chromosome Deletion | 2 | 0.0 |
Carrier Proteins/*genetics/metabolism | 4 | 1.0 |
Cell Line | 3 | 0.0 |
Microscopy, Confocal | 2 | 0.0 |
Microscopy, Electron | 2 | 0.0 |
Mutation/*physiology | 2 | 1.0 |
Tissue Distribution | 5 | 0.0 |
Adenosinetriphosphatase/genetics/metabolism | 3 | 12.0 |
Carrier Proteins/genetics/metabolism | 2 | 1.0 |
Hepatolenticular Degeneration/*genetics/*metabolism | 2 | 100.0 |
Homeostasis | 4 | 1.0 |
Iron/*metabolism | 2 | 1.0 |
Alleles | 3 | 0.0 |
DNA/analysis | 3 | 0.0 |
DNA Mutational Analysis/methods | 2 | 0.0 |
*Gene Frequency | 2 | 0.0 |
*Polymorphism, Single Nucleotide | 2 | 0.0 |
Hepatolenticular Degeneration/genetics/metabolism | 3 | 75.0 |
Menkes Kinky Hair Syndrome/genetics | 3 | 60.0 |
Mice | 12 | 0.0 |
Mice, Inbred BALB C | 3 | 0.0 |
Disease Models, Animal | 5 | 0.0 |
Liver/metabolism | 2 | 0.0 |
*Gene Deletion | 3 | 0.0 |
Polymorphism, Genetic/genetics | 2 | 0.0 |
Adenosinetriphosphatase/genetics | 6 | 14.0 |
Carrier Proteins/genetics | 5 | 1.0 |
Hepatolenticular Degeneration/ethnology/*genetics | 2 | 100.0 |
*Mutation, Missense | 3 | 0.0 |
Pedigree | 6 | 0.0 |
Taiwan | 2 | 1.0 |
Adenosinetriphosphatase/*metabolism | 3 | 7.0 |
Biological Transport/drug effects | 2 | 0.0 |
Cell Membrane/metabolism | 2 | 0.0 |
Golgi Apparatus/metabolism | 6 | 3.0 |
Adenosinetriphosphatase/genetics/*metabolism | 3 | 10.0 |
Hepatolenticular Degeneration/enzymology/genetics | 2 | 66.0 |
Recombinant Fusion Proteins/metabolism | 3 | 0.0 |
Amino Acid Substitution | 4 | 0.0 |
Ceruloplasmin/metabolism | 3 | 11.0 |
Fluorescent Antibody Technique, Indirect | 2 | 0.0 |
Hela Cells | 2 | 0.0 |
Mutagenesis, Site-Directed | 6 | 0.0 |
Amino Acid Sequence | 12 | 0.0 |
Binding Sites | 5 | 0.0 |
Circular Dichroism | 2 | 0.0 |
Hepatolenticular Degeneration/*metabolism | 3 | 60.0 |
Molecular Sequence Data | 18 | 0.0 |
Protein Structure, Tertiary | 4 | 0.0 |
Zinc/metabolism | 2 | 2.0 |
Antineoplastic Agents/pharmacology | 2 | 0.0 |
Biological Transport | 9 | 0.0 |
Blotting, Western | 6 | 0.0 |
Cell Line, Tumor | 3 | 0.0 |
Cloning, Molecular | 5 | 0.0 |
Dose-Response Relationship, Drug | 2 | 0.0 |
Protein Binding | 3 | 0.0 |
Time Factors | 2 | 0.0 |
Polymerase Chain Reaction/methods | 2 | 0.0 |
DNA Transposable Elements | 2 | 1.0 |
Frameshift Mutation | 4 | 1.0 |
Japan | 4 | 0.0 |
Mutation, Missense | 3 | 0.0 |
Sequence Deletion | 6 | 0.0 |
Comparative Study | 7 | 0.0 |
Liver/*metabolism | 3 | 0.0 |
Carcinoma, Hepatocellular | 2 | 0.0 |
Cells, Cultured | 4 | 0.0 |
Heterozygote Detection | 3 | 0.0 |
Introns | 3 | 0.0 |
Polymorphism, Genetic | 3 | 0.0 |
Chromosome Mapping | 6 | 0.0 |
*Disease Models, Animal | 5 | 1.0 |
Dog Diseases/*genetics/metabolism | 2 | 40.0 |
Hepatolenticular Degeneration/genetics | 8 | 80.0 |
*Molecular Chaperones | 2 | 1.0 |
Pseudogenes | 2 | 1.0 |
Sequence Alignment | 4 | 0.0 |
Sequence Homology, Amino Acid | 2 | 0.0 |
Species Specificity | 2 | 0.0 |
Adenosinetriphosphatase/*chemistry/*genetics | 2 | 50.0 |
Cation Transport Proteins/*chemistry/*genetics | 2 | 100.0 |
Protein Folding | 3 | 0.0 |
Temperature | 2 | 0.0 |
Immunohistochemistry | 7 | 0.0 |
Menkes Kinky Hair Syndrome/genetics/*metabolism | 2 | 66.0 |
Mutagenesis, Insertional | 2 | 0.0 |
Heterozygote | 3 | 0.0 |
Sensitivity and Specificity | 2 | 0.0 |
Dogs | 4 | 0.0 |
DNA Primers | 5 | 0.0 |
In Situ Hybridization, Fluorescence | 2 | 0.0 |
*Saccharomyces cerevisiae Proteins | 3 | 0.0 |
Gene Expression | 2 | 0.0 |
DNA Primers/genetics | 3 | 0.0 |
Age of Onset | 3 | 0.0 |
DNA, Complementary/genetics | 3 | 0.0 |
Genetic Complementation Test | 3 | 0.0 |
Iron/metabolism | 2 | 1.0 |
Recombinant Fusion Proteins/immunology | 2 | 1.0 |
Cell Compartmentation | 2 | 0.0 |
Fibroblasts | 3 | 0.0 |
Models, Statistical | 2 | 1.0 |
Blotting, Northern | 2 | 0.0 |
Pregnancy | 3 | 0.0 |
Mutagenesis | 4 | 0.0 |
Retrospective Studies | 2 | 0.0 |
DNA, Complementary | 2 | 0.0 |
Point Mutation | 5 | 0.0 |
Recombinant Proteins/chemistry/metabolism | 2 | 0.0 |
Adenosine Triphosphate/metabolism | 2 | 0.0 |
Menkes Kinky Hair Syndrome/genetics/metabolism | 3 | 100.0 |
Hepatolenticular Degeneration/enzymology/*genetics | 2 | 66.0 |
Adenosinetriphosphatase/metabolism | 4 | 3.0 |
Polymorphism, Restriction Fragment Length | 2 | 0.0 |
RNA Splicing | 3 | 0.0 |
Prognosis | 2 | 0.0 |
In Situ Hybridization/methods | 2 | 1.0 |
Cation Transport Proteins/genetics | 2 | 12.0 |
Repetitive Sequences, Nucleic Acid | 2 | 0.0 |
*DNA Mutational Analysis | 2 | 1.0 |
Italy/ethnology | 2 | 5.0 |
Restriction Mapping | 2 | 0.0 |
Mice, Mutant Strains | 3 | 0.0 |
Cation Transport Proteins/metabolism | 3 | 30.0 |
*Exons | 2 | 0.0 |
Binding Sites/genetics | 2 | 0.0 |
Child, Preschool | 4 | 0.0 |
Mutation/*genetics | 4 | 0.0 |
*Drug Resistance, Neoplasm | 2 | 1.0 |
Green Fluorescent Proteins | 2 | 0.0 |
Reference Values | 2 | 0.0 |
Cation Transport Proteins/genetics/*metabolism | 2 | 16.0 |
Survival Rate | 2 | 0.0 |
Adenosinetriphosphatase/*genetics/*metabolism | 2 | 28.0 |
Cation Transport Proteins/*genetics/*metabolism | 2 | 25.0 |
Subcellular Fractions/enzymology | 2 | 2.0 |